| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |